Finance

Lists
2096:HKG
Simcere Pharmaceutical Group Ltd
HK$ ११.०२
+१.७५%
(+०.१९) 1D
अक्टोबर १६, १६:०८:१४ GMT+८  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2096...
Open
HK$ १०.८५
High
HK$ ११.२९
Low
HK$ १०.८५
Mkt. cap
२८.३० अरब
Avg. vol.
४०.१६ लाख
Volume
५८.०१ लाख
Dividend
१.८८%
Quarterly dividend
HK$ ०.०५
Ex-dividend date
२०२५ जुन १८
P/E ratio
१६.५४
52-wk high
HK$ १४.३८
52-wk low
HK$ ९.०७
EPS
HK$ ०.६७
Shares outstanding
२.५७ अरब
No. of employees
७ हजार
Open
HK$ १०.८५
High
HK$ ११.२९
Low
HK$ १०.८५
Mkt. cap
२८.३० अरब
Avg. vol.
४०.१६ लाख
Volume
५८.०१ लाख
Dividend
१.८८%
Quarterly dividend
HK$ ०.०५
Ex-dividend date
२०२५ जुन १८
P/E ratio
१६.५४
52-wk high
HK$ १४.३८
52-wk low
HK$ ९.०७
EPS
HK$ ०.६७
Shares outstanding
२.५७ अरब
No. of employees
७ हजार
News stories
From web sources and news partners
Profile
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
About Simcere Pharmaceutical Group Ltd
CEORen Jinsheng
Employees७.०६ हजार
Founded१९९५
HeadquartersNanjing, Jiangsu, चीन
Sector-
Previous reports
Loading Previous Earnings...
Revenue
Net income
All values in CNY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२.०७ अरब
२.०७ अरब
२.२९ अरब
२.२९ अरब
Cost of goods sold
३६.५२ करोड
३६.५२ करोड
३८.२६ करोड
३८.२६ करोड
Cost of revenue
३६.५२ करोड
३६.५२ करोड
३८.२६ करोड
३८.२६ करोड
Research and development expenses
४६.५३ करोड
४६.५३ करोड
४१.२५ करोड
४१.२५ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
९४.९५ करोड
९४.९५ करोड
१.०१ अरब
१.०१ अरब
Operating expense
१.३६ अरब
१.३६ अरब
१.३९ अरब
१.३९ अरब
Total operating expenses
१.७२ अरब
१.७२ अरब
१.७७ अरब
१.७७ अरब
Operating income
३५.१३ करोड
३५.१३ करोड
५२.१० करोड
५२.१० करोड
Other non operating income
-
-
-
-
EBT including unusual items
४२.५९ करोड
४२.५९ करोड
४८.३४ करोड
४८.३४ करोड
EBT excluding unusual items
३४.८९ करोड
३४.८९ करोड
५३.१६ करोड
५३.१६ करोड
Income tax expense
५.५७ करोड
५.५७ करोड
७.०१ करोड
७.०१ करोड
Effective tax rate
१३.०८%
१३.०८%
१४.५०%
१४.५०%
Other operating expenses
-५.६३ करोड
-५.६३ करोड
-४.२९ करोड
-४.२९ करोड
Net income
३७.०२ करोड
३७.०२ करोड
४१.४४ करोड
४१.४४ करोड
Net profit margin
१७.८६%
१७.८६%
१८.०९%
१८.०९%
Earnings per share
-
-
-
-
Interest and investment income
१.४६ करोड
१.४६ करोड
२.४२ करोड
२.४२ करोड
Interest expense
-२.३६ करोड
-२.३६ करोड
-२.४६ करोड
-२.४६ करोड
Net interest expenses
-९०.३२ लाख
-९०.३२ लाख
-४.१६ लाख
-४.१६ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
४४.९७ करोड
४४.९७ करोड
६०.६० करोड
६०.६० करोड
Gain or loss from assets sale
-१.१६ लाख
-१.१६ लाख
-
-
AI content may include mistakes. Learn more
Google एपहरू